Awareness, Care & Treatment In Obesity Management - An Observation in Switzerland

Completed

• Conditions: Obesity
• Interventions: Other: No treatment given

• Registration Number: NCT05232786
• Lead Sponsor: Novo Nordisk A/S

Brief Summary

ACTION Switzerland is a cross-sectional, observational, descriptive, and exploratory survey-based study without collection of laboratory data. The study is not related to any specific treatment options or pharmaceutical product. Collection of data will be performed via quantitative online survey by a third-party vendor.

The goal of this study is to provide insights to drive awareness around the needs of People Living with Obesity (PLwO) and Health Care Professionals (HCPs) involved in obesity treatment and management.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2022-01-12
• Study First Submitted QC: 2022-02-09
• Study First Posted: 2022-02-10
• Study Start: 2022-03-08
• Primary Completion: 2022-04-08
• Study Completion: 2022-04-08
• Status Verified: 2022-10
• Last Update Submitted: 2022-10-25
• Last Update Posted: 2022-10-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1152

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Health Care Professionals (HCPs)	No treatment given	HCPs treating people who have obesity
People / Person Living with Obesity (PLwO)	No treatment given	From online, general population consumer panels

Primary Outcome Measures

Name	Time	Method
Proportion of PLwO who made serious weight loss effort	At the time of survey response (Day 1)	Number of weight loss efforts; percentage of patients
Weight loss barriers	At the time of survey response (Day 1)	Multi-select from defined list
Weight loss motivators	At the time of survey response (Day 1)	Multi-select from defined list
Attitudes towards obesity and weight management and Interactions of PLwOs with HCPs	At the time of survey response (Day 1)	5-point Likert scales (e.g., agreement, impact, frequency); - Proportion of responses in each category will be reported.
Weight loss management	At the time of survey response (Day 1)	Multi-select from defined list

Trial Locations

Locations (1)

Novo Nordisk Investigational Site; 🇨🇭 Zürich, Switzerland